270 related articles for article (PubMed ID: 5998373)
1. [Drug therapy of chronic inflammatory liver diseases].
Vetter K; Kettler LH; Kaschube I; Lüder W
Dtsch Z Verdau Stoffwechselkr; 1966 Dec; 26(3):121-9. PubMed ID: 5998373
[No Abstract] [Full Text] [Related]
2. [Reflections on prednisone therapy of patients with liver diseases].
Teichmann W
Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):25-7. PubMed ID: 5501421
[No Abstract] [Full Text] [Related]
3. [Our experience with long-term therapy of chronic liver diseases using Superanabolon Spofa].
Svacinka P; Horký J; Blahníková L
Vnitr Lek; 1970 Dec; 16(12):1181-7. PubMed ID: 5491517
[No Abstract] [Full Text] [Related]
4. [Treatment of chronic diseases of the liver].
Loginov AS
Ter Arkh; 1977; 49(1):3-9. PubMed ID: 867234
[No Abstract] [Full Text] [Related]
5. [Nitrogen resorption and nitrogen retention in patients with chronic liver diseases].
Vetter K; Kaschube I; Lüder W; Aust L
Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):61-4. PubMed ID: 5501430
[No Abstract] [Full Text] [Related]
6. [Therapy of liver diseases, possibilities and problems].
Renger F
Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):9-13. PubMed ID: 4100481
[No Abstract] [Full Text] [Related]
7. [On the therapy of chronic inflammatory liver diseases without or with vitamin B 12-folic acid].
Burgmann W
Munch Med Wochenschr; 1966 Sep; 108(37):1805-8. PubMed ID: 6014771
[No Abstract] [Full Text] [Related]
8. [Effect of anabolic steroids on protein metabolism under various protein administrations in chronic liver disease patients].
Blahníková L; Horký J
Z Ernahrungswiss Suppl; 1972; 13():105-12. PubMed ID: 4510113
[No Abstract] [Full Text] [Related]
9. [Corticoid therapy in liver diseases].
Runcan V; Buligescu L
Med Interna (Bucur); 1970 Mar; 22(3):259-64. PubMed ID: 5444364
[No Abstract] [Full Text] [Related]
10. [Hepagrisevit forte in chronic liver diseases].
Kollatz E; Kramer A; Schopper W; Siede W
Med Klin; 1965 Dec; 60(50):2032-5. PubMed ID: 5331151
[No Abstract] [Full Text] [Related]
11. [Side-effects of glucocorticoids in liver therapy].
Möller E; Brinkmann W; Weber O; Wildhirt E
Dtsch Med Wochenschr; 1969 Jun; 94(26):1371-3 passim. PubMed ID: 5787349
[No Abstract] [Full Text] [Related]
12. [Therapeutic efficiency of purified liver extract with an increased amount of vitamin B 12 in coenzymatic form in patients with liver diseases and rheumatoid arthritis].
Guglielmi G; Garbagnati N; Iaschi P; Ciavarelli F; Ferrantelli D
Clin Ter; 1969 Nov; 51(3):227-44. PubMed ID: 5407318
[No Abstract] [Full Text] [Related]
13. [Experiences with Vitamin B-12 therapy of chronic liver diseases in a resort practice].
André W
Munch Med Wochenschr; 1966 Mar; 108(11):610-1. PubMed ID: 6013869
[No Abstract] [Full Text] [Related]
14. [Immunosuppressive drugs in the treatment of liver diseases (author's transl)].
Magnenat P
Ther Umsch; 1979 May; 36(5):432-8. PubMed ID: 451956
[No Abstract] [Full Text] [Related]
15. [Glucocorticoids in chronic liver diseases].
Maier KP; Talke H; Gerok W
Dtsch Med Wochenschr; 1975 Mar; 100(11):560-3. PubMed ID: 1116441
[No Abstract] [Full Text] [Related]
16. [Glucocorticoids and immunosuppressive agents in liver diseases].
Arpa Gutierrez FJ; Silva Pozo J
Rev Esp Enferm Apar Dig; 1970 Dec; 32(7):763-82. PubMed ID: 4926636
[No Abstract] [Full Text] [Related]
17. [Therapy of chronic hepatitis and liver cirrhosis with the oral antidiabetic tolbutamide (Orabet)].
Schimmelpfennig W; Wagner K; Schneider G; Theuer D; Schimmelpfennig R; Zimmermann HB; Hecht A
Dtsch Gesundheitsw; 1969 Oct; 24(44):2074-9. PubMed ID: 5385540
[No Abstract] [Full Text] [Related]
18. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
Wildhirt E
Munch Med Wochenschr; 1968 Oct; 110(40):2313-4. PubMed ID: 5761605
[No Abstract] [Full Text] [Related]
19. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?].
Heinrich HC
Munch Med Wochenschr; 1968 Oct; 110(40):2311-2. PubMed ID: 5761604
[No Abstract] [Full Text] [Related]
20. [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. I. Changes in the general dynamics of the disease. II. Slowing-down of the chronicization process].
Nicolaescu T; Stoiculescu P; Bittman E; Bordeianu A; Gheorghe N; Pintilescu V; Metz L
Med Interna (Bucur); 1974 Apr; 26(4):453-64. PubMed ID: 4839352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
